Amdocs (DOX) Financials

$84.55 +0.45 (+0.54%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$84.52 -0.03 (-0.04%)

As of 04/15/2025 04:14 PM Eastern

Annual Income Statements for Amdocs

This table shows Amdocs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	422	446	409	437	354	479	498	688	550	541	493
Consolidated Net Income / (Loss)	422	446	409	437	354	479	498	688	550	543	496
Net Income / (Loss) Continuing Operations	422	446	409	437	354	479	498	688	550	543	496
Total Pre-Tax Income	490	513	485	513	422	568	583	814	648	636	591
Total Operating Income	496	516	483	517	428	570	595	599	665	654	629
Total Gross Profit	1,257	1,294	1,310	1,359	1,380	1,433	1,413	1,478	1,619	1,728	1,755
Total Revenue	3,564	3,644	3,718	3,867	3,975	4,087	4,169	4,289	4,577	4,888	5,005
Operating Revenue	3,564	3,644	3,718	3,867	3,975	4,087	4,169	4,289	4,577	4,888	5,005
Total Cost of Revenue	2,307	2,349	2,408	2,508	2,595	2,653	2,756	2,811	2,958	3,160	3,250
Operating Cost of Revenue	2,307	2,349	2,408	2,508	2,595	2,653	2,756	2,811	2,958	3,160	3,250
Total Operating Expenses	761	778	827	842	951	864	819	879	954	1,074	1,127
Selling, General & Admin Expense	445	440	465	473	481	492	459	487	529	571	573
Research & Development Expense	258	255	252	259	277	274	282	313	355	375	361
Amortization Expense	58	70	110	110	108	97	78	79	71	57	62
Restructuring Charge	0.00	13	-	-	-	-	-	0.00	0.00	71	131
Total Other Income / (Expense), net	-6.10	-2.54	1.56	-4.42	-6.77	-1.86	-11	216	-16	-18	-38
Other Income / (Expense), net	-	-	-	-4.42	-	-1.86	-11	216	-16	-18	-38
Income Tax Expense	67	67	75	76	67	88	85	126	99	93	95
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	0.00	0.00	2.25	3.12
Basic Earnings per Share	$2.65	$2.89	$2.74	$2.99	$2.49	$3.49	$3.73	$5.36	$4.47	$4.52	$4.27
Weighted Average Basic Shares Outstanding	156.70M	151.15M	147.13M	144.39M	140.18M	134.77M	131.54M	124.87M	120.84M	117.35M	112.89M
Diluted Earnings per Share	$2.62	$2.85	$2.71	$2.96	$2.47	$3.47	$3.71	$5.32	$4.44	$4.49	$4.25
Weighted Average Diluted Shares Outstanding	156.70M	151.15M	147.13M	144.39M	140.18M	134.77M	131.54M	124.87M	120.84M	117.35M	112.89M
Weighted Average Basic & Diluted Shares Outstanding	156.70M	151.15M	147.13M	144.39M	140.18M	134.77M	131.54M	124.87M	120.84M	117.35M	112.89M
Cash Dividends to Common per Share	$0.60	$0.67	$0.76	$0.86	$0.97	$1.11	$1.27	$1.41	$1.55	$1.70	$1.87

No quarterly income statements for Amdocs are available.

This table details how cash moves in and out of Amdocs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	89	-68	-267	-119	-231	53	512	-274	-136	-53	-174
Net Cash From Operating Activities	709	773	620	636	557	656	658	926	757	823	724
Net Cash From Continuing Operating Activities	709	773	620	636	557	656	658	926	757	823	724
Net Income / (Loss) Continuing Operations	422	446	409	437	354	479	498	688	550	543	496
Consolidated Net Income / (Loss)	422	446	409	437	354	479	498	688	550	543	496
Depreciation Expense	163	175	212	215	211	206	198	209	225	196	193
Amortization Expense	-	-	-	-	0.00	0.00	0.14	0.55	0.56	0.58	0.60
Non-Cash Adjustments To Reconcile Net Income	42	39	36	40	49	39	35	-170	65	92	110
Changes in Operating Assets and Liabilities, net	83	113	-37	-55	-57	-68	-73	198	-82	-9.07	-76
Net Cash From Investing Activities	-299	-380	-441	-185	-362	-87	-462	-329	-263	-224	-127
Net Cash From Continuing Investing Activities	-299	-380	-441	-185	-362	-87	-462	-329	-263	-224	-127
Purchase of Property, Plant & Equipment	-112	-121	-130	-133	-231	-128	-206	-210	-227	-124	-105
Acquisitions	-181	-263	-283	-18	-355	-61	-249	-143	-24	-122	-87
Purchase of Investments	-390	-250	-371	-282	-76	0.00	-0.75	-277	-34	0.00	-9.06
Sale of Property, Plant & Equipment	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00
Divestitures	-	-	-	-	-	0.00	0.00	289	10	0.00	0.00
Sale and/or Maturity of Investments	379	253	362	278	303	101	0.00	18	22	26	69
Other Investing Activities, net	3.87	1.41	-19	-30	-3.16	0.62	-6.10	-6.08	-8.53	-4.30	5.32
Net Cash From Financing Activities	-322	-461	-446	-570	-426	-517	315	-871	-630	-651	-771
Net Cash From Continuing Financing Activities	-322	-461	-446	-570	-426	-517	315	-871	-630	-651	-771
Repurchase of Common Equity	-372	-454	-413	-341	-419	-398	-361	-680	-508	-490	-563
Payment of Dividends	-91	-101	-109	-122	-87	-152	-164	-177	-186	-201	-216
Other Financing Activities, net	132	84	96	92	81	34	96	87	65	39	8.17
Cash Interest Paid	0.63	0.55	0.58	1.15	2.01	7.35	5.39	19	17	19	35
Cash Income Taxes Paid	59	51	50	68	56	76	45	146	80	156	188

No quarterly cash flow statements for Amdocs are available.

This table presents Amdocs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	5,185	5,325	5,331	5,279	5,348	5,293	6,342	6,512	6,390	6,426	6,386
Total Current Assets	2,424	2,378	2,100	2,048	1,721	1,676	2,075	2,067	2,003	1,912	1,771
Cash & Equivalents	1,103	1,036	769	650	419	472	983	709	573	520	346
Short-Term Investments	321	318	327	330	100	0.00	0.75	257	245	222	168
Accounts Receivable	716	715	819	865	972	988	861	867	947	944	1,028
Prepaid Expenses	135	159	186	204	230	216	230	235	238	225	228
Plant, Property, & Equipment, net	289	309	332	356	497	525	608	699	794	791	756
Total Noncurrent Assets	2,472	2,637	2,899	2,875	3,131	3,092	3,659	3,746	3,593	3,723	3,859
Goodwill	1,925	2,049	2,212	2,221	2,445	2,463	2,579	2,623	2,663	2,749	2,845
Intangible Assets	181	253	282	177	265	205	296	259	178	182	161
Other Noncurrent Operating Assets	366	336	406	477	420	424	784	864	752	793	854
Total Liabilities & Shareholders' Equity	5,185	5,325	5,331	5,279	5,348	5,293	6,342	6,512	6,390	6,426	6,386
Total Liabilities	1,789	1,918	1,878	1,705	1,856	1,750	2,676	2,877	2,830	2,859	2,887
Total Current Liabilities	1,201	1,364	1,366	1,173	1,295	1,208	1,216	1,304	1,253	1,353	1,471
Accounts Payable	143	112	137	126	195	177	110	121	134	293	306
Accrued Expenses	422	609	612	668	707	648	594	612	613	635	779
Current Deferred Revenue	157	198	173	113	132	118	127	237	254	171	115
Current Employee Benefit Liabilities	221	224	244	265	261	266	227	274	209	215	231
Other Current Liabilities	-	-	-	-	-	0.00	59	59	43	40	40
Total Noncurrent Liabilities	589	554	512	532	561	542	1,460	1,573	1,577	1,505	1,416
Long-Term Debt	-	-	-	-	-	0.00	644	645	645	646	646
Noncurrent Deferred & Payable Income Tax Liabilities	311	306	227	219	225	208	258	305	312	253	198
Other Noncurrent Operating Liabilities	278	248	285	313	336	335	558	624	620	607	572
Total Equity & Noncontrolling Interests	3,396	3,407	3,454	3,574	3,492	3,542	3,665	3,635	3,560	3,567	3,499
Total Preferred & Common Equity	3,396	3,407	3,454	3,574	3,449	3,500	3,623	3,593	3,518	3,524	3,457
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,396	3,407	3,454	3,574	3,449	3,500	3,623	3,593	3,518	3,524	3,457
Common Stock	3,059	3,187	3,327	3,463	3,592	3,672	3,812	3,956	4,110	4,249	4,418
Retained Earnings	3,504	3,848	4,145	4,457	4,674	5,013	5,342	5,851	6,212	6,550	6,828
Treasury Stock	-3,157	-3,611	-4,025	-4,365	-4,784	-5,182	-5,543	-6,223	-6,732	-7,221	-7,784
Accumulated Other Comprehensive Income / (Loss)	-9.97	-17	6.10	19	-33	-2.55	12	9.34	-72	-53	-4.41
Noncontrolling Interest	-	-	-	0.00	43	43	43	43	43	43	42

No quarterly balance sheets for Amdocs are available.

This table displays calculated financial ratios and metrics derived from Amdocs' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.51%	2.24%	2.05%	4.01%	2.78%	2.81%	2.02%	2.87%	6.72%	6.79%	2.40%
EBITDA Growth	-47.10%	4.91%	0.61%	4.73%	-12.13%	20.97%	1.06%	30.93%	-14.67%	-4.68%	-5.75%
EBIT Growth	-48.54%	4.10%	-6.36%	6.16%	-16.50%	32.59%	2.72%	39.60%	-20.37%	-1.86%	-7.12%
NOPAT Growth	2.32%	4.91%	-9.00%	7.98%	-18.27%	33.58%	5.53%	-0.29%	11.32%	-0.96%	-5.41%
Net Income Growth	2.35%	5.70%	-8.26%	6.72%	-18.87%	35.29%	3.84%	38.27%	-20.17%	-1.19%	-8.59%
EPS Growth	3.56%	8.78%	-4.91%	9.23%	-16.55%	40.49%	6.92%	43.40%	-16.54%	1.13%	-5.35%
Operating Cash Flow Growth	5.77%	8.93%	-19.72%	2.56%	-12.40%	17.79%	0.27%	40.67%	-18.26%	8.71%	-11.94%
Free Cash Flow Firm Growth	2.62%	-9.51%	-65.54%	228.41%	-104.53%	2,195.26%	-60.00%	302.88%	-20.59%	-3.02%	-22.83%
Invested Capital Growth	1.53%	4.19%	12.54%	1.43%	14.58%	3.30%	11.54%	-3.24%	2.21%	2.44%	4.64%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.27%	35.52%	35.24%	35.16%	34.71%	35.08%	33.90%	34.46%	35.38%	35.35%	35.07%
EBITDA Margin	18.48%	18.96%	18.69%	18.82%	16.09%	18.93%	18.75%	23.87%	19.09%	17.04%	15.68%
Operating Margin	13.91%	14.16%	12.99%	13.38%	10.78%	13.94%	14.27%	13.96%	14.53%	13.38%	12.56%
EBIT Margin	13.91%	14.16%	12.99%	13.26%	10.78%	13.90%	13.99%	18.99%	14.17%	13.02%	11.81%
Profit (Net Income) Margin	11.85%	12.25%	11.01%	11.30%	8.92%	11.73%	11.94%	16.05%	12.01%	11.11%	9.92%
Tax Burden Percent	86.23%	86.90%	84.45%	85.17%	84.07%	84.43%	85.35%	84.54%	84.75%	85.32%	83.97%
Interest Burden Percent	98.77%	99.51%	100.32%	100.00%	98.42%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	13.77%	13.10%	15.55%	14.83%	15.93%	15.57%	14.65%	15.46%	15.25%	14.68%	16.03%
Return on Invested Capital (ROIC)	19.74%	20.13%	16.89%	17.10%	12.94%	15.92%	15.63%	15.02%	16.81%	16.27%	14.87%
ROIC Less NNEP Spread (ROIC-NNEP)	20.19%	20.32%	16.76%	17.50%	13.69%	16.23%	18.37%	-49.97%	22.44%	27.43%	-164.59%
Return on Net Nonoperating Assets (RNNOA)	-7.09%	-7.02%	-4.96%	-4.67%	-2.90%	-2.29%	-1.81%	3.84%	-1.54%	-1.04%	-0.82%
Return on Equity (ROE)	12.66%	13.12%	11.93%	12.43%	10.03%	13.63%	13.81%	18.86%	15.27%	15.24%	14.05%
Cash Return on Invested Capital (CROIC)	18.22%	16.03%	5.09%	15.68%	-0.66%	12.67%	4.72%	18.32%	14.63%	13.86%	10.33%
Operating Return on Assets (OROA)	9.80%	9.82%	9.07%	9.67%	8.06%	10.67%	10.03%	12.67%	10.05%	9.93%	9.23%
Return on Assets (ROA)	8.35%	8.49%	7.68%	8.23%	6.67%	9.01%	8.56%	10.71%	8.52%	8.47%	7.75%
Return on Common Equity (ROCE)	12.66%	13.12%	11.93%	12.43%	9.97%	13.47%	13.65%	18.64%	15.09%	15.05%	13.88%
Return on Equity Simple (ROE_SIMPLE)	12.43%	13.10%	11.85%	12.22%	10.28%	13.70%	13.74%	19.16%	15.62%	15.41%	14.36%
Net Operating Profit after Tax (NOPAT)	427	448	408	441	360	481	508	506	563	558	528
NOPAT Margin	11.99%	12.31%	10.97%	11.39%	9.06%	11.77%	12.18%	11.80%	12.31%	11.42%	10.55%
Net Nonoperating Expense Percent (NNEP)	-0.45%	-0.19%	0.13%	-0.40%	-0.76%	-0.32%	-2.74%	64.99%	-5.62%	-11.15%	179.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	13.40%	13.25%	12.73%
Cost of Revenue to Revenue	64.73%	64.48%	64.76%	64.85%	65.29%	64.92%	66.10%	65.54%	64.62%	64.65%	64.93%
SG&A Expenses to Revenue	12.49%	12.08%	12.50%	12.23%	12.10%	12.05%	11.00%	11.36%	11.55%	11.68%	11.45%
R&D to Revenue	7.24%	7.00%	6.79%	6.70%	6.96%	6.70%	6.77%	7.30%	7.75%	7.67%	7.21%
Operating Expenses to Revenue	21.36%	21.36%	22.24%	21.78%	23.93%	21.14%	19.64%	20.50%	20.85%	21.97%	22.51%
Earnings before Interest and Taxes (EBIT)	496	516	483	513	428	568	583	814	648	636	591
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	658	691	695	728	640	774	782	1,024	874	833	785
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.85	2.27	2.22	2.36	2.50	2.44	2.01	2.66	2.71	2.83	2.97
Price to Tangible Book Value (P/TBV)	4.88	6.99	8.00	7.17	11.66	10.26	9.73	13.42	14.08	16.84	22.74
Price to Revenue (P/Rev)	1.76	2.12	2.07	2.18	2.17	2.09	1.75	2.22	2.08	2.04	2.05
Price to Earnings (P/E)	14.90	17.32	18.77	19.30	24.30	17.80	14.62	13.86	17.34	18.47	20.81
Dividend Yield	1.51%	1.35%	1.49%	1.49%	1.63%	1.82%	2.35%	1.94%	2.03%	2.06%	2.14%
Earnings Yield	6.71%	5.77%	5.33%	5.18%	4.12%	5.62%	6.84%	7.21%	5.77%	5.41%	4.80%
Enterprise Value to Invested Capital (EV/IC)	2.33	2.90	2.65	2.87	2.74	2.64	2.07	2.80	2.77	2.86	2.88
Enterprise Value to Revenue (EV/Rev)	1.42	1.81	1.83	1.93	2.05	1.98	1.70	2.16	2.05	2.03	2.09
Enterprise Value to EBITDA (EV/EBITDA)	7.71	9.55	9.77	10.24	12.72	10.47	9.06	9.05	10.76	11.93	13.30
Enterprise Value to EBIT (EV/EBIT)	10.24	12.78	14.05	14.52	18.99	14.27	12.14	11.38	14.49	15.61	17.66
Enterprise Value to NOPAT (EV/NOPAT)	11.87	14.71	16.63	16.91	22.59	16.85	13.95	18.30	16.68	17.80	19.78
Enterprise Value to Operating Cash Flow (EV/OCF)	7.15	8.53	10.94	11.71	14.60	12.35	10.76	10.01	12.42	12.08	14.41
Enterprise Value to Free Cash Flow (EV/FCFF)	12.86	18.47	55.17	18.44	0.00	21.16	46.22	15.01	19.17	20.90	28.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.06	0.06	0.00	0.00	0.00	0.20	0.18	0.18	0.18	0.18
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.18	0.18	0.18	0.18
Financial Leverage	-0.35	-0.35	-0.30	-0.27	-0.21	-0.14	-0.10	-0.08	-0.07	-0.04	0.01
Leverage Ratio	1.52	1.55	1.55	1.51	1.50	1.51	1.61	1.76	1.79	1.80	1.81
Compound Leverage Factor	1.50	1.54	1.56	1.51	1.48	1.51	1.61	1.76	1.79	1.80	1.81
Debt to Total Capital	5.82%	6.07%	5.47%	0.00%	0.00%	0.00%	16.87%	15.06%	15.34%	15.33%	15.59%
Short-Term Debt to Total Capital	5.82%	6.07%	5.47%	0.00%	0.00%	0.00%	2.27%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.61%	15.06%	15.34%	15.33%	15.59%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	1.24%	1.20%	0.96%	0.99%	1.01%	1.02%	1.02%
Common Equity to Total Capital	94.18%	93.93%	94.53%	100.00%	98.76%	98.80%	82.16%	83.95%	83.65%	83.65%	83.39%
Debt to EBITDA	0.32	0.32	0.29	0.00	0.00	0.00	0.95	0.63	0.74	0.78	0.82
Net Debt to EBITDA	-1.84	-1.64	-1.29	0.00	0.00	0.00	-0.31	-0.31	-0.20	-0.12	0.17
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.82	0.63	0.74	0.78	0.82
Debt to NOPAT	0.49	0.49	0.49	0.00	0.00	0.00	1.47	1.27	1.15	1.16	1.22
Net Debt to NOPAT	-2.84	-2.53	-2.20	0.00	0.00	0.00	-0.47	-0.63	-0.31	-0.17	0.25
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	1.27	1.27	1.15	1.16	1.22
Altman Z-Score	4.34	4.66	4.70	5.40	5.11	5.48	3.93	4.46	4.57	4.72	4.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.61%	1.22%	1.18%	1.16%	1.18%	1.20%	1.21%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.02	1.74	1.54	1.75	1.33	1.39	1.71	1.59	1.60	1.41	1.20
Quick Ratio	1.78	1.52	1.40	1.57	1.15	1.21	1.52	1.41	1.41	1.25	1.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	394	357	123	404	-18	383	153	617	490	475	367
Operating Cash Flow to CapEx	635.71%	641.16%	476.79%	476.87%	241.08%	512.45%	320.25%	439.94%	333.04%	661.48%	686.69%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.70	0.69	0.70	0.73	0.75	0.77	0.72	0.67	0.71	0.76	0.78
Accounts Receivable Turnover	5.11	5.09	4.85	4.59	4.33	4.17	4.51	4.96	5.05	5.17	5.07
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	12.63	12.18	11.60	11.25	9.33	8.00	7.36	6.56	6.13	6.17	6.47
Accounts Payable Turnover	16.76	18.46	19.37	19.06	16.16	14.29	19.23	24.30	23.14	14.77	10.85
Days Sales Outstanding (DSO)	71.39	71.66	75.26	79.45	84.32	87.50	80.94	73.53	72.32	70.62	71.94
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	21.78	19.78	18.84	19.15	22.58	25.54	18.98	15.02	15.77	24.70	33.66
Cash Conversion Cycle (CCC)	49.61	51.88	56.41	60.31	61.74	61.96	61.95	58.51	56.55	45.92	38.28
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,181	2,273	2,558	2,594	2,973	3,071	3,425	3,314	3,387	3,470	3,631
Invested Capital Turnover	1.65	1.64	1.54	1.50	1.43	1.35	1.28	1.27	1.37	1.43	1.41
Increase / (Decrease) in Invested Capital	33	91	285	37	378	98	354	-111	73	83	161
Enterprise Value (EV)	5,073	6,593	6,786	7,449	8,135	8,104	7,080	9,263	9,396	9,935	10,440
Market Capitalization	6,288	7,727	7,682	8,429	8,611	8,533	7,278	9,541	9,526	9,989	10,266
Book Value per Share	$21.22	$21.74	$22.85	$24.29	$23.89	$24.97	$26.88	$27.31	$28.17	$29.16	$29.46
Tangible Book Value per Share	$8.06	$7.05	$6.35	$7.99	$5.12	$5.94	$5.55	$5.41	$5.42	$4.91	$3.85
Total Capital	3,606	3,627	3,654	3,574	3,492	3,542	4,409	4,280	4,205	4,213	4,145
Total Debt	210	220	200	0.00	0.00	0.00	744	645	645	646	646
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	644	645	645	646	646
Net Debt	-1,214	-1,134	-896	-980	-519	-472	-240	-321	-173	-97	132
Capital Expenditures (CapEx)	112	121	130	133	231	128	206	210	227	124	105
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.76	-119	-161	-104	-93	-3.99	-26	-202	-68	-184	-214
Debt-free Net Working Capital (DFNWC)	1,433	1,235	934	876	426	468	958	764	750	558	300
Net Working Capital (NWC)	1,223	1,015	734	876	426	468	858	764	750	558	300
Net Nonoperating Expense (NNE)	5.26	2.21	-1.31	3.77	5.69	1.57	9.76	-182	14	15	32
Net Nonoperating Obligations (NNO)	-1,214	-1,134	-896	-980	-519	-472	-240	-321	-173	-97	132
Total Depreciation and Amortization (D&A)	163	175	212	215	211	206	199	209	225	196	194
Debt-free, Cash-free Net Working Capital to Revenue	0.25%	-3.28%	-4.34%	-2.69%	-2.35%	-0.10%	-0.61%	-4.71%	-1.48%	-3.77%	-4.28%
Debt-free Net Working Capital to Revenue	40.22%	33.89%	25.13%	22.64%	10.71%	11.44%	22.99%	17.81%	16.40%	11.42%	6.00%
Net Working Capital to Revenue	34.33%	27.85%	19.75%	22.64%	10.71%	11.44%	20.59%	17.81%	16.40%	11.42%	6.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.65	$2.89	$2.74	$2.99	$2.49	$0.00	$3.73	$5.36	$4.47	$4.52	$4.27
Adjusted Weighted Average Basic Shares Outstanding	159.01M	151.15M	147.13M	144.39M	140.18M	0.00	131.54M	124.87M	120.84M	117.35M	112.89M
Adjusted Diluted Earnings per Share	$2.62	$2.85	$2.71	$2.96	$2.47	$0.00	$3.71	$5.32	$4.44	$4.49	$4.25
Adjusted Weighted Average Diluted Shares Outstanding	161.37M	151.15M	147.13M	144.39M	140.18M	0.00	131.54M	124.87M	120.84M	117.35M	112.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	156.70M	151.15M	147.13M	144.39M	140.18M	0.00	131.54M	124.87M	120.84M	117.35M	112.89M
Normalized Net Operating Profit after Tax (NOPAT)	427	460	408	441	432	481	508	506	563	618	638
Normalized NOPAT Margin	11.99%	12.62%	10.97%	11.39%	10.86%	11.77%	12.18%	11.80%	12.31%	12.65%	12.75%
Pre Tax Income Margin	13.74%	14.09%	13.04%	13.26%	10.61%	13.90%	13.99%	18.99%	14.17%	13.02%	11.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.54%	22.59%	26.70%	27.82%	24.63%	31.79%	32.95%	25.78%	33.86%	37.03%	43.53%
Augmented Payout Ratio	109.67%	124.35%	127.70%	105.79%	142.92%	114.81%	105.45%	124.56%	126.40%	127.19%	156.99%

No quarterly metrics and ratios for Amdocs are available.

Frequently Asked Questions About Amdocs' Financials

When does Amdocs's fiscal year end?

According to the most recent income statement we have on file, Amdocs' financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Amdocs' net income changed over the last 10 years?

Amdocs' net income appears to be on an upward trend, with a most recent value of $496.32 million in 2024, rising from $422.12 million in 2014. The previous period was $542.96 million in 2023.

What is Amdocs's operating income?

Amdocs's total operating income in 2024 was $628.61 million, based on the following breakdown:

Total Gross Profit: $1.76 billion
Total Operating Expenses: $1.13 billion

How has Amdocs revenue changed over the last 10 years?

Over the last 10 years, Amdocs' total revenue changed from $3.56 billion in 2014 to $5.00 billion in 2024, a change of 40.4%.

How much debt does Amdocs have?

Amdocs' total liabilities were at $2.89 billion at the end of 2024, a 1.0% increase from 2023, and a 61.3% increase since 2014.

How much cash does Amdocs have?

In the past 10 years, Amdocs' cash and equivalents has ranged from $346.09 million in 2024 to $1.10 billion in 2014, and is currently $346.09 million as of their latest financial filing in 2024.

How has Amdocs' book value per share changed over the last 10 years?

Over the last 10 years, Amdocs' book value per share changed from 21.22 in 2014 to 29.46 in 2024, a change of 38.9%.

Remove Ads

Related Companies

This page (NASDAQ:DOX) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amdocs (DOX) Financials

Frequently Asked Questions About Amdocs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amdocs (DOX) Financials

Annual Income Statements for Amdocs

Quarterly Income Statements for Amdocs

Annual Cash Flow Statements for Amdocs

Quarterly Cash Flow Statements for Amdocs

Annual Balance Sheets for Amdocs

Quarterly Balance Sheets for Amdocs

Annual Metrics and Ratios for Amdocs

Quarterly Metrics and Ratios for Amdocs

Frequently Asked Questions About Amdocs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools